Putnam BioRevolution ETF Rating $31.67 +0.17 (+0.54%) (As of 11/1/2024 08:57 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Putnam BioRevolution ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy2.75Holdings in SYNB have an aggregate rating of Moderate Buy based on 582 analyst ratings issued in the past year covering 34 companies (91.4% of the portfolio).SYNB Aggregate Price Target$37.9219.75% UpsideHigh Prediction$45.49Average Prediction$37.92Low Prediction$29.49Holdings in SYNB have an aggregate price target of $37.92 and a range of $29.49 to $45.49 covering 34 companies (91.4% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 34 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.91%TMOThermo Fisher Scientific$550.29-1.4%4.9588 of 5 stars2.86$649.33 18.0%226.31%DHRDanaher$246.02-0.7%4.946 of 5 stars2.74$287.16 16.7%195.26%BIOBio-Rad Laboratories$366.92-0.4%4.143 of 5 stars2.60$391.80 6.8%5Earnings ReportAnalyst Upgrade5.16%NVDANVIDIA$137.25+1.4%4.6185 of 5 stars2.95$143.07 4.2%434.96%NVZMYNovozymes A/S$62.76+0.0%3.2637 of 5 stars2.333News Coverage4.61%GOOGLAlphabet$168.10-1.9%4.4202 of 5 stars2.90$205.51 22.3%41Earnings ReportDividend AnnouncementInsider SellingAnalyst Revision4.33%REGNRegeneron Pharmaceuticals$837.31-0.7%4.8423 of 5 stars2.71$1,097.25 31.0%21Analyst Forecast4.30%CTVACorteva$60.95+0.1%4.0354 of 5 stars2.67$62.84 3.1%21Upcoming EarningsDividend Announcement4.29%ABBVAbbVie$201.09-1.2%4.8473 of 5 stars2.84$201.00 0.0%20Earnings ReportDividend IncreaseAnalyst UpgradeAnalyst Revision4.14%LLYEli Lilly and Company$808.06-1.3%4.8927 of 5 stars2.84$1,009.00 24.9%19Earnings ReportDividend AnnouncementAnalyst Revision3.47%DDDuPont de Nemours$81.53-1.2%4.7636 of 5 stars2.54$94.83 16.3%13Upcoming EarningsPositive News3.38%ASNDAscendis Pharma A/S$126.88+1.3%3.0801 of 5 stars2.92$195.92 54.4%13Upcoming EarningsAnalyst ForecastNews CoveragePositive News3.33%EXASExact Sciences$71.88+3.0%4.2332 of 5 stars2.94$80.64 12.2%16Upcoming Earnings3.18%AZNAstraZeneca$71.21-0.3%3.9102 of 5 stars2.91$89.75 26.0%11Options Volume2.72%AVTRAvantor$22.41+0.4%4.8679 of 5 stars2.80$27.57 23.0%152.58%DARDarling Ingredients$40.12+1.8%4.0692 of 5 stars2.90$55.60 38.6%102.37%ZTSZoetis$174.47-4.1%4.9851 of 5 stars3.10$221.44 26.9%10News CoverageGap Down2.06%CDNSCadence Design Systems$288.18+2.2%4.8864 of 5 stars2.75$323.17 12.1%12Earnings ReportAnalyst Revision1.85%BIIBBiogen$172.96-0.5%4.838 of 5 stars2.62$262.83 52.0%26Earnings ReportAnalyst Revision1.71%NGVTIngevity$42.06+0.1%2.6374 of 5 stars2.50$52.17 24.0%6Earnings Report1.69%ONONON$46.65+0.3%2.6506 of 5 stars2.81$49.74 6.6%21Analyst Forecast1.62%PPGPPG Industries$124.66+0.2%4.6812 of 5 stars2.65$149.93 20.3%17Insider SellingPositive News1.43%VRTXVertex Pharmaceuticals$470.34-0.2%3.193 of 5 stars2.48$492.50 4.7%291.42%TWSTTwist Bioscience$41.29-0.7%2.4858 of 5 stars2.67$51.22 24.1%91.40%BGBunge Global$84.19+1.9%4.6626 of 5 stars2.63$118.00 40.2%81.24%ARGXargenx$583.17-2.1%2.5053 of 5 stars2.83$598.44 2.6%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.05%LULULululemon Athletica$319.00-0.7%4.3489 of 5 stars2.58$354.55 11.1%310.93%TECHBio-Techne$75.76+0.6%4.1451 of 5 stars2.67$81.78 7.9%9Earnings ReportDividend AnnouncementAnalyst Upgrade0.91%MEDPMedpace$315.93-1.1%4.8552 of 5 stars2.45$380.00 20.3%110.77%BMRNBioMarin Pharmaceutical$66.00-0.9%4.9702 of 5 stars2.67$94.16 42.7%21Earnings ReportAnalyst Revision0.72%ALNYAlnylam Pharmaceuticals$270.92-1.1%3.8177 of 5 stars2.75$294.50 8.7%24Earnings ReportAnalyst Forecast0.69%RCKTRocket Pharmaceuticals$16.78-1.2%4.3158 of 5 stars2.90$51.75 208.4%100.39%CRSPCRISPR Therapeutics$51.32+1.1%2.8093 of 5 stars2.37$75.19 46.5%190.18%LNZALanzaTech Global$1.74+1.1%1.3183 of 5 stars2.75$6.33 264.0%4Upcoming Earnings This page (NYSEARCA:SYNB) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
